Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Locally Recurrent”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00044291
What this trial is testing

Phase III Study of Atamestane Plus Toremifene Versus Letrozole in Advanced Breast Cancer

Who this might be right for
Breast NeoplasmsNeoplasms, Hormone-dependent
Intarcia Therapeutics 865
Testing effectiveness (Phase 2)Study completedNCT00103259
What this trial is testing

Bortezomib With or Without Irinotecan in Treating Patients With Locally Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck

Who this might be right for
Recurrent Squamous Cell Carcinoma of the HypopharynxRecurrent Squamous Cell Carcinoma of the LarynxRecurrent Squamous Cell Carcinoma of the Lip and Oral Cavity+22 more
National Cancer Institute (NCI) 71
Testing effectiveness (Phase 2)Ended earlyNCT01051791
What this trial is testing

Phase II Study of RAD001 Head and Neck Cancer

Who this might be right for
Squamous Cell Carcinoma of the Head and Neck
Julie E. Bauman, MD, MPH 13
Testing effectiveness (Phase 2)Study completedNCT05316818
What this trial is testing

Triplet (FOLFOXIRI) vs. Doublet (FOLFOX or FOLFIRI) Regimen as a 1st Line Treatment in Metastatic Colorectal Carcinoma

Who this might be right for
Metastatic Colorectal Cancer
Kasr El Aini Hospital 64
Testing effectiveness (Phase 2)Study completedNCT01613768
What this trial is testing

Eribulin Mesylate in Treating Patients With Recurrent or Metastatic Salivary Gland Cancer

Who this might be right for
Recurrent Salivary Gland CancerStage IVA Salivary Gland CancerStage IVB Salivary Gland Cancer+1 more
University of Washington 29
Testing effectiveness (Phase 2)Ended earlyNCT04390243
What this trial is testing

Binimetinib and Encorafenib for the Treatment of Pancreatic Cancer in Patients With a Somatic BRAF V600E Mutation

Who this might be right for
Locally Advanced Pancreatic CarcinomaMetastatic Pancreatic CarcinomaRecurrent Pancreatic Carcinoma+2 more
Academic and Community Cancer Research United 6
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07128693
What this trial is testing

A Single-center, Multicohort, Phase II Clinical Study Evaluating the Combination Therapy of Sacituzumab Tirumotecan in Patients With Unresectable, Locally Advanced, Recurrent, or Metastatic Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Squamous Cell Carcinoma
The First Affiliated Hospital of Zhengzhou University 60
Not applicableUnknownNCT02688725
What this trial is testing

Post-Mastectomy Surveillance to Detect Recurrence in Breast Cancer Patients

Who this might be right for
Breast Cancer
Providence Health & Services 100
Large-scale testing (Phase 3)Active Not RecruitingNCT04305496
What this trial is testing

Capivasertib+Fulvestrant vs Placebo+Fulvestrant as Treatment for Locally Advanced (Inoperable) or Metastatic HR+/HER2- Breast Cancer

Who this might be right for
Locally Advanced (Inoperable) or Metastatic Breast Cancer
AstraZeneca 818
Testing effectiveness (Phase 2)Looking for participantsNCT05440227
What this trial is testing

PG2 Injection for the Treatment of moderate-to Severe Fatigue in Breast Cancer Patients

Who this might be right for
Cancer-related Fatigue
PhytoHealth Corporation 36
Testing effectiveness (Phase 2)Study completedNCT00005066
What this trial is testing

O6-benzylguanine and Carmustine in Treating Patients With Recurrent, Metastatic, or Locally Advanced Soft Tissue Sarcoma

Who this might be right for
Sarcoma
University of Chicago 12
Testing effectiveness (Phase 2)Study completedNCT01802320
What this trial is testing

Akt Inhibitor MK2206 in Treating Patients With Previously Treated Colon or Rectal Cancer That is Metastatic or Locally Advanced and Cannot Be Removed by Surgery

Who this might be right for
Colon Mucinous AdenocarcinomaColon Signet Ring Cell AdenocarcinomaRectal Mucinous Adenocarcinoma+13 more
National Cancer Institute (NCI) 18
Not applicableStudy completedNCT05495308
What this trial is testing

"Oncologic Results and Risk Factors for Recurrence in Patients With Locally Advanced Rectal Cancer and Pathologic Complete Response After Neoadjuvant Treatment. Results From an Observational Retrospective Multicenter Long-term Follow-up Study".

Who this might be right for
Rectal Cancer, AdenocarcinomaRectal Cancer Stage IIRectal Cancer Stage III+2 more
Hospital San Carlos, Madrid 4
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06728618
What this trial is testing

Preoperative Tislelizumab -Cetuximab - Chemotherapy Followed by Salvage Surgery and Adjuvant Tislelizumab -Cetuximab for Resectable, Locally Recurrent Oral and Oropharyngeal Squamous Cell Carcinoma

Who this might be right for
Oral Squamous Cell Carcinoma (OSCC)Oropharyngeal Squamous Cell Carcinoma (SCC)Resectable Oral and Oropharyngeal Squamous Cell Carcinoma+1 more
Shanghai Zhongshan Hospital
Testing effectiveness (Phase 2)Study completedNCT03406468
What this trial is testing

Re-Induction After Initial Response With Immune Therapy With Radiotherapy in Lung Cancer

Who this might be right for
Non-Small Cell Carcinoma of Lung, TNM Stage 4
Maastricht Radiation Oncology 36
Testing effectiveness (Phase 2)Ended earlyNCT00085410
What this trial is testing

Bortezomib in Treating Patients With Unresectable Locally Advanced or Metastatic Adenocarcinoma of the Bile Duct or Gallbladder

Who this might be right for
Adenocarcinoma of the Extrahepatic Bile DuctAdenocarcinoma of the GallbladderAdvanced Adult Primary Liver Cancer+7 more
National Cancer Institute (NCI) 20
Early research (Phase 1)Study completedNCT03297710
What this trial is testing

TAS-102 and Radiation Therapy in Treating Patients With Rectal Cancer That Is Locally Recurrent, Metastatic, or Cannot Be Removed by Surgery

Who this might be right for
Rectal AdenocarcinomaRecurrent Rectal CarcinomaStage IV Rectal Cancer AJCC v7+2 more
Mayo Clinic 7
Testing effectiveness (Phase 2)UnknownNCT02051868
What this trial is testing

International Multicentre Study in Advanced Anal Cancer Comparing Cisplatin Plus 5 FU vs Carboplatin Plus Weekly Paclitaxel

Who this might be right for
Squamous Cell Carcinoma of the Anus
Royal Marsden NHS Foundation Trust 80
Early research (Phase 1)Study completedNCT00003167
What this trial is testing

Gene Therapy in Treating Patients With Advanced Bladder Cancer

Who this might be right for
Recurrent Bladder CancerStage I Bladder CancerStage II Bladder Cancer+3 more
National Cancer Institute (NCI) 24
Testing effectiveness (Phase 2)Looking for participantsNCT06942416
What this trial is testing

Iparomlimab and Tuvonralimab With Chemoradiation for the Treatment of Locally Recurrent and Oligometastatic Cervical Cancer

Who this might be right for
Cervical CancerNeoplasm Recurrence, LocalOligometastatic
Shandong Cancer Hospital and Institute 36
Next Page
28